Prolacta Bioscience

Biotechnology ResearchCalifornia, United States201-500 Employees

Prolacta Bioscience is a mid-sized biotechnology firm based in City of Industry, California, focused on neonatal nutrition through 100% human milk-based fortifiers and formulas for premature and critically ill infants. Its products aim to reduce complications and hospital costs in NICUs, and the company notes that it introduced the world’s first 100% human milk-based fortifier, with more than half of Level 3 and 4 U.S. NICUs using its offerings. The clinical record includes more than 30 peer-reviewed studies suggesting shorter NICU stays and improved outcomes for infants born under 1,250 grams compared with cow-milk-based products, and Surgifort is the first FDA-approved human milk-based fortifier for term infants recovering from gastroschisis surgery.

The primary customers are U.S. Level 3 and 4 NICUs and hospitals caring for critically ill or premature newborns seeking nutrition-based improvements. In October 2024, the company named Sandra Sullivan director of clinical education and professional development, reflecting an emphasis on clinical education.

Sign up for free to view info

Email Format Employee directory